Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Ji Zongfei"'
Autor:
Ji Zongfei, Chen Lingli, Sun Ying, Ma Lingying, Zhang Lijuan, Liu Dongmei, Dai Xiaomin, Hou Yingyong, Chen Huiyong, Ma Lili, Jiang Lindi
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-8 (2022)
Abstract Objectives In IgG4-related disease, the relationship between pathological findings and relapse has not been well established. This study aimed to identify the clinical and pathological predictors of disease relapse in IgG4-RD. Methods Patien
Externí odkaz:
https://doaj.org/article/70918b9f9cb0449b88414cce6761489b
Autor:
Ji Zongfei, Zhang Lijuan, Sun Ying, Liu Dongmei, Wu Sifan, Kong Xiufang, Ma Lingying, Liu Yun, Ma Lili, Chen Huiyong, Jiang Lindi
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Objective: To compare the clinical outcomes of patients with active immunoglobulin G (IgG) 4 related disease (IgG4-RD) receiving tocilizumab versus those receiving cyclophosphamide (CYC). Methods: This IgG4-RD registry study was a prospective cohort
Externí odkaz:
https://doaj.org/article/b8da410adbf240f5a00f2efc8b77b12b
Autor:
Ji Zongfei, Chen Rongyi, Cui Xiaomeng, Ma Lili, Ma Lingying, Kong Xiufang, Dai Xiaomin, Zhang Zhuojun, Chen Huiyong, Sun Ying, Jiang Lindi
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Background: The remarkable mechanisms of storiform fibrosis and the formation of high levels of IgG4 with a pathogenic germinal center (GC) in the inflammatory tissue of IgG4-RD remains unknown and may be responsible for the unsatisfactory therapeuti
Externí odkaz:
https://doaj.org/article/c920a10be64a4247b2213162518e5e83
Autor:
Sun Ying, Cui Xiaomeng, Dai Xiaomin, Lin Jiang, Lv Peng, Ma Lili, Chen Rongyi, Ji Zongfei, Chen Huiyong, Jiang Lindi
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Background: Leflunomide (LEF) has been considered as an alternative treatment for Takayasu arteritis (TA); however, data on its efficacy are still scanty. Objective: To investigate the efficacy and safety of LEF versus cyclophosphamide (CYC) for init
Externí odkaz:
https://doaj.org/article/8972ba73895b4964a4fac1a111ee786c
Autor:
Dai, Xiaojuan, Sun, Ying, Ma, Lingying, Hou, Jun, Wang, Li, Gong, Yu, Sun, Xiaoning, Wu, Sifan, Wang, Jinghua, Ji, Zongfei, Chen, Huiyong, Ma, Lili, Jiang, Lindi, Kong, Xiufang
Publikováno v:
In Translational Research May 2023 255:128-139
Autor:
Ji, Zongfei1 (AUTHOR) ji.zongfei@zs-hospital.sh.cn, Lu, Weiqi2 (AUTHOR), Wu, Sifan1 (AUTHOR), Zhang, Yong2 (AUTHOR), Meng, Dan1,3 (AUTHOR), Zhang, Xiao1 (AUTHOR), Dai, Xiaojuan1 (AUTHOR), Chen, Huiyong1 (AUTHOR), Ma, Lili1,3 (AUTHOR), Sun, Ying1 (AUTHOR), Jiang, Lindi1,4 (AUTHOR) jiang.lindi@zs-hospital.sh.cn, Kong, Xiufang1,4 (AUTHOR) jiang.lindi@zs-hospital.sh.cn
Publikováno v:
International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p13735. 18p.
Autor:
Wu, Sifan, Kong, Xiufang, Cui, Xiaomeng, Chen, Huiyong, Ma, Lili, Dai, Xiaomin, Ji, Zongfei, Yan, Yan, Huang, Qingrong, Sun, Ying *, Jiang, Lindi
Publikováno v:
In Joint Bone Spine October 2021 88(5)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Li Yanshan, Cui Xiaomeng, Chen Rongyi, Jiang Lindi, Dai Xiaomin, Ji Zongfei, Ma Lingying, Kong Xiufang, Lin Jiang, Li-li Ma, Wu Sifan, Sun Ying, Yu Wenshu
Publikováno v:
Modern Rheumatology. 31:1135-1141
Objectives Hydroxychloroquine (HCQ), an anti-malarial drug, is widely used in the treatment of rheumatic diseases. However, the benefits of HCQ in the treatment of Takayasu arteritis (TA) remain unclear, especially in terms of alleviation of vascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4608784fe01d55ea1a1e1bcf2bc0020e
https://doi.org/10.1080/14397595.2021.1879347
https://doi.org/10.1080/14397595.2021.1879347
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.